Elite in Eosinophilic Asthma

Krishnan K. Nair-Parameswaran

St. Joseph's Hospital, 
Hamilton, ON, CA 
Elite in Eosinophilic Asthma
St. Joseph's Hospital, 
Hamilton, ON, CA 
OverviewLocationsClinical Research

Overview

Krishnan Nair-Parameswaran practices in Hamilton, Canada. Mr. Nair-Parameswaran is rated as an Elite expert by MediFind in the treatment of Eosinophilic Asthma. His top areas of expertise are Eosinophilic Asthma, Asthma, Chronic Eosinophilic Pneumonia, Simple Pulmonary Eosinophilia, and Lung Transplant.

His clinical research consists of co-authoring 252 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 30 articles and participated in 1 clinical trial in the study of Eosinophilic Asthma.

Gender
Male

Locations

St. Joseph's Hospital, Hamilton, ON, Canada
Other Locations
St, Hamilton, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Prospective Longitudinal Study to Characterize and Understand the Clinical Relevance of SARS-CoV2 Related Ventilation and Perfusion Injury Evaluated by V/Q SPECT-CT in an Asthmatic and Healthy Population
Prospective Longitudinal Study to Characterize and Understand the Clinical Relevance of SARS-CoV2 Related Ventilation and Perfusion Injury Evaluated by V/Q SPECT-CT in an Asthmatic and Healthy Population
Enrollment Status: Completed
Publish Date: August 14, 2025
Intervention Type: Other
Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma and Persistent Sputum Eosinophilia Despite Standard Dose Therapy
Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma and Persistent Sputum Eosinophilia Despite Standard Dose Therapy
Enrollment Status: Completed
Publish Date: January 25, 2024
Intervention Type: Biological
Study Drug: Reslizumab
Study Phase: Phase 4
Prevalence and Clinical Relevance of Ventilation Heterogeneity and Luminal Cellular Inflammation in Lung Cancer Patients Prior to Lung Resection
Prevalence and Clinical Relevance of Ventilation Heterogeneity and Luminal Cellular Inflammation in Lung Cancer Patients Prior to Lung Resection
Enrollment Status: Enrolling_by_invitation
Publish Date: January 05, 2024
Intervention Type: Other
Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies
Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies
Enrollment Status: Completed
Publish Date: January 20, 2023
Intervention Type: Biological
Study Drug: Benralizumab
Study Phase: Phase 3
A Two-arm, Placebo-controlled Randomized Clinical Trial to Evaluate the Effect of Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma With a T2 Immune Signature
A Two-arm, Placebo-controlled Randomized Clinical Trial to Evaluate the Effect of Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma With a T2 Immune Signature
Enrollment Status: Completed
Publish Date: January 20, 2023
Intervention Type: Biological
Study Drug: Dupilumab
Study Phase: Phase 3
Randomized Double Blind Placebo Controlled Trial of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis
Randomized Double Blind Placebo Controlled Trial of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis
Enrollment Status: Completed
Publish Date: April 04, 2018
Intervention Type: Drug, Biological
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

252 Total Publications

Clinical Remission by a Comprehensive Severe Asthma Management Strategy Guided by Airway Inflammometry and Bioimaging.
Clinical Remission by a Comprehensive Severe Asthma Management Strategy Guided by Airway Inflammometry and Bioimaging.
Journal: American journal of respiratory and critical care medicine
Published: June 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nair-Parameswaran's expertise for a condition
ConditionClose
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile